ODDB.org: Open Drug Database | Médicaments | Information professionnelle

Home - Ipro sur Tapazole®

Information professionnelle sur Tapazole®:

Eli Lilly (Suisse) SA

Information professionnelle complète	DDD	imprimé
Forme gal./Grpe.th.	Composit.	Propriétés	Pharm.cinét.	Indic./emploi	Posolog./mode d'empl.	Précautions	Effets indésir.
Interact.	Surdosage	Remarques	Num. Swissmedic	Mise à jour

H03BB02 - Thiamazole

ATC-DDD Version 2016. Source: WHO

H - Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins

This group comprises all hormonal preparations for systemic use, except:
- Insulins, see A10.
- Anabolic steroids, see A14.
- Catecholamines, see C01C and R03C.
- Sex hormones, see G03.
- Sex hormones used in treatment of neoplastic diseases, see L02.
- Metreleptin used for treatment of complications of leptin deficiency in patients with generalised lipodystrophy is classified in A16AA.

The DDDs are generally based on the treatment or diagnosis of endocrine disorders.

H03 - Thyroid Therapy

Iodine-therapy products that influence hormonal synthesis or function are classified in H03C - Iodine therapy.

H03B - Antithyroid Preparations

This group comprises preparations used in the treatment of hyperthyrosis.

The DDDs are based on the treatment of hyperthyrosis.

H03BB - Sulfur-Containing Imidazole Derivatives

H03BB02 - Thiamazole

Concentr.	Adm.Route	Note
	O

2025	©ywesee GmbH